YTHD Antibodies

Santa Cruz Biotechnology features a diverse variety of YTHD Antibodies for specific detection and analysis of YTH domain-containing proteins. YTHD Antibodies are validated for multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). YTHD proteins play a crucial role in RNA metabolism and are involved in the recognition of N6-methyladenosine (m6A) modifications on RNA, which is essential for regulating gene expression and cellular processes. RNA modification patterns influence development, differentiation, and cellular responses to environmental stimuli. Research has shown that YTHD protein activity impacts various diseases, including cancer and neurological disorders. Understanding YTHD protein function and regulation provides valuable insights into RNA biology and disease mechanisms. Investigating m6A modifications and their readers continues to reveal new aspects of gene regulation. YTHD research using Santa Cruz Biotechnology monoclonal antibodies enables scientists to advance our understanding of RNA biology and its role in human health and disease.